Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$7.12 - $20.24 $724,673 - $2.06 Million
-101,780 Reduced 75.0%
33,935 $677,000
Q2 2022

Aug 15, 2022

BUY
$5.1 - $10.0 $196,936 - $386,150
38,615 Added 39.77%
135,715 $935,000
Q1 2022

May 13, 2022

BUY
$8.34 - $14.69 $462,870 - $815,295
55,500 Added 133.41%
97,100 $903,000
Q2 2021

Aug 12, 2021

BUY
$22.86 - $30.95 $432,054 - $584,955
18,900 Added 83.26%
41,600 $1.04 Million
Q4 2020

Feb 03, 2021

SELL
$34.9 - $51.08 $97,720 - $143,024
-2,800 Reduced 10.98%
22,700 $792,000
Q3 2020

Nov 16, 2020

BUY
$32.95 - $50.25 $840,225 - $1.28 Million
25,500 New
25,500 $1.27 Million

Others Institutions Holding FMTX

About Forma Therapeutics Holdings, Inc.


  • Ticker FMTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,860,400
  • Market Cap $958M
  • Description
  • Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...
More about FMTX
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.